Results 211 to 220 of about 9,662,184 (369)
Objective Mutations in TARDBP (encoding TDP‐43) are associated with the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and include familial missense mutations where there are a lack of models and mechanisms examining how they are pathogenic.
Ziyaan A. Harji +10 more
wiley +1 more source
Role of Polysomnography in Tracheostomy Decannulation in Neuromuscular Disease: A Case Report. [PDF]
Pereira P, Vieira AL, Tizón S.
europepmc +1 more source
Assessment of Parental Needs and Quality of Life in Children with a Rare Neuromuscular Disease (Pompe Disease): A Quantitative-Qualitative Study. [PDF]
Benedetto L +4 more
europepmc +1 more source
Intravenous immunoglobulin for neuromuscular disease: costs, benefits and reimbursement [PDF]
John W. Griffin, Richard AC Hughes
openalex +1 more source
Objective Myotonic dystrophy type 1 (DM1) is a highly variable, multisystemic genetic disorder caused by a CTG repeat expansion in the 3′ untranslated region of DMPK. Toxicity is exerted by repeat‐containing DMPK transcripts that sequester muscleblind‐like (MBNL) proteins and lead to deleterious yet predictable changes in alternative splicing.
Samuel T. Carrell +3 more
wiley +1 more source
A novel mutation in FDX2 provides insights into the pathogenesis of MEOAL mitochondrial neuromuscular disease. [PDF]
Doni D +20 more
europepmc +1 more source
Objective An enduring puzzle in many inherited neurological disorders is the late onset of symptoms despite expression of function‐impairing mutant protein early in life. We examined the basis for onset of impairment in spinocerebellar ataxia type 6 (SCA6), a canonical late‐onset neurodegenerative ataxia which results from a polyglutamine expansion in ...
Haoran Huang +10 more
wiley +1 more source

